{"id":"https://openalex.org/W2304873291","doi":null,"title":"Resource Utilization for Chemotherapy-Induced Nausea and Vomiting Events in Patients with Solid Tumors Treated with Antiemetic Regimens.","display_name":"Resource Utilization for Chemotherapy-Induced Nausea and Vomiting Events in Patients with Solid Tumors Treated with Antiemetic Regimens.","publication_year":2015,"publication_date":"2015-07-01","ids":{"openalex":"https://openalex.org/W2304873291","mag":"2304873291","pmid":"https://pubmed.ncbi.nlm.nih.gov/26380034","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4567059"},"language":"en","primary_location":{"id":"pmh:oai:pubmedcentral.nih.gov:4567059","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4567059","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Am Health Drug Benefits","raw_type":"Text"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4567059","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5072563567","display_name":"Lee Steven Schwartzberg","orcid":"https://orcid.org/0000-0002-7433-3428","observed_orcids":["https://orcid.org/0000-0002-7433-3428"]},"institutions":[{"id":"https://openalex.org/I160606119","display_name":"University of Tennessee Health Science Center","ror":"https://ror.org/0011qv509","country_code":"US","type":"education","lineage":["https://openalex.org/I160606119"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lee Schwartzberg","raw_affiliation_strings":["Medical Director, West Clinic, and Chief, Division of Hematology/Oncology, University of Tennessee Health Science Center, Memphis"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Director, West Clinic, and Chief, Division of Hematology/Oncology, University of Tennessee Health Science Center, Memphis","institution_ids":["https://openalex.org/I160606119"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050046440","display_name":"Brooke S. Harrow","orcid":"https://orcid.org/0000-0002-3998-3417","observed_orcids":["https://orcid.org/0000-0002-3998-3417"]},"institutions":[{"id":"https://openalex.org/I4210120660","display_name":"Tesaro (United States)","ror":"https://ror.org/02r3fkw61","country_code":"US","type":"company","lineage":["https://openalex.org/I4210120660"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brooke Harrow","raw_affiliation_strings":["Director, Medical Affairs Research-HEOR, TESARO, Waltham, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Director, Medical Affairs Research-HEOR, TESARO, Waltham, MA","institution_ids":["https://openalex.org/I4210120660"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071873633","display_name":"Lincy Subha Lal","orcid":"https://orcid.org/0000-0002-9123-2434","observed_orcids":["https://orcid.org/0000-0002-9123-2434"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lincy S Lal","raw_affiliation_strings":["Director, HEOR Clinical Specialty Solutions, Cardinal Health, Dallas, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Director, HEOR Clinical Specialty Solutions, Cardinal Health, Dallas, TX","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014601476","display_name":"Janna Radtchenko","orcid":"https://orcid.org/0000-0002-0462-5505","observed_orcids":["https://orcid.org/0000-0002-0462-5505"]},"institutions":[{"id":"https://openalex.org/I4210150323","display_name":"Cardinal Health (United States)","ror":"https://ror.org/03pd82777","country_code":"US","type":"company","lineage":["https://openalex.org/I4210150323"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Janna Radtchenko","raw_affiliation_strings":["Director, Client Services Specialty Solutions, Cardinal Health, Dallas, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Director, Client Services Specialty Solutions, Cardinal Health, Dallas, TX","institution_ids":["https://openalex.org/I4210150323"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5073060840","display_name":"Gary H. Lyman","orcid":"https://orcid.org/0000-0002-0823-8086","observed_orcids":["https://orcid.org/0000-0002-0823-8086"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gary H Lyman","raw_affiliation_strings":["Co-Director, Hutchinson Institute for Cancer Outcomes Research, Public Health Sciences and Clinical Research Divisions, Fred Hutchinson Cancer Research Center, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Co-Director, Hutchinson Institute for Cancer Outcomes Research, Public Health Sciences and Clinical Research Divisions, Fred Hutchinson Cancer Research Center, Seattle, WA","institution_ids":["https://openalex.org/I4210089486"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":3.2123,"has_fulltext":false,"cited_by_count":42,"citation_normalized_percentile":{"value":0.91553018,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":96,"max":98},"biblio":{"volume":"8","issue":"5","first_page":"273","last_page":"82"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11785","display_name":"Nausea and vomiting management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11785","display_name":"Nausea and vomiting management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12708","display_name":"Economic and Financial Impacts of Cancer","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chemotherapy-induced-nausea-and-vomiting","display_name":"chemotherapy-induced nausea and vomiting","score":0.996999979019165},{"id":"https://openalex.org/keywords/antiemetic-therapy","display_name":"antiemetic therapy","score":0.746999979019165},{"id":"https://openalex.org/keywords/nk1-receptor-antagonists","display_name":"NK1 receptor antagonists","score":0.9559999704360962},{"id":"https://openalex.org/keywords/5-ht3-receptor-antagonists","display_name":"5-HT3 receptor antagonists","score":0.9940000176429749},{"id":"https://openalex.org/keywords/highly-emetogenic-chemotherapy","display_name":"highly emetogenic chemotherapy","score":0.8619999885559082},{"id":"https://openalex.org/keywords/moderately-emetogenic-chemotherapy","display_name":"moderately emetogenic chemotherapy","score":0.9919999837875366},{"id":"https://openalex.org/keywords/healthcare-resource-utilization","display_name":"healthcare resource utilization","score":0.8259999752044678},{"id":"https://openalex.org/keywords/emergency-department-visits","display_name":"emergency department visits","score":0.8989999890327454},{"id":"https://openalex.org/keywords/hospitalization","display_name":"hospitalization","score":0.6859999895095825},{"id":"https://openalex.org/keywords/guideline-adherence","display_name":"guideline adherence","score":0.7480000257492065},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.7990000247955322},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":0.9879999756813049},{"id":"https://openalex.org/keywords/carboplatin","display_name":"carboplatin","score":1.0},{"id":"https://openalex.org/keywords/cost-of-care","display_name":"cost of care","score":0.675000011920929}],"concepts":[{"id":"https://openalex.org/C2780884295","wikidata":"https://www.wikidata.org/wiki/Q575136","display_name":"Antiemetic","level":3,"score":0.9000521302223206},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.8395727872848511},{"id":"https://openalex.org/C2780852908","wikidata":"https://www.wikidata.org/wiki/Q127076","display_name":"Vomiting","level":2,"score":0.8258937001228333},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6576807498931885},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.6284162998199463},{"id":"https://openalex.org/C2779924295","wikidata":"https://www.wikidata.org/wiki/Q5090630","display_name":"Chemotherapy-induced nausea and vomiting","level":4,"score":0.5680536031723022},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.4312742352485657},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.41904395818710327},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.25496071577072144}],"mesh":[],"locations_count":2,"locations":[{"id":"pmh:oai:pubmedcentral.nih.gov:4567059","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4567059","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Am Health Drug Benefits","raw_type":"Text"},{"id":"pmid:26380034","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26380034","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American health & drug benefits","raw_type":"Journal Article"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:4567059","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4567059","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Am Health Drug Benefits","raw_type":"Text"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":30,"referenced_works":["https://openalex.org/W1561023139","https://openalex.org/W1786056333","https://openalex.org/W1876492466","https://openalex.org/W1968008450","https://openalex.org/W1974362328","https://openalex.org/W1990642584","https://openalex.org/W1991565938","https://openalex.org/W1993434718","https://openalex.org/W1997707842","https://openalex.org/W2012564804","https://openalex.org/W2041576066","https://openalex.org/W2046417971","https://openalex.org/W2057428133","https://openalex.org/W2065765429","https://openalex.org/W2074318951","https://openalex.org/W2087575003","https://openalex.org/W2089425012","https://openalex.org/W2098832321","https://openalex.org/W2123267000","https://openalex.org/W2123337081","https://openalex.org/W2129168200","https://openalex.org/W2133300915","https://openalex.org/W2140429392","https://openalex.org/W2144365381","https://openalex.org/W2145821236","https://openalex.org/W2148594906","https://openalex.org/W2167208736","https://openalex.org/W2168688660","https://openalex.org/W2466914012","https://openalex.org/W4240043517"],"related_works":["https://openalex.org/W2187568845","https://openalex.org/W2765530808","https://openalex.org/W2163144507","https://openalex.org/W2653082094","https://openalex.org/W4206011837","https://openalex.org/W3169388996","https://openalex.org/W2123337081","https://openalex.org/W2896732797","https://openalex.org/W57763074","https://openalex.org/W2087575003"],"abstract_inverted_index":{"BACKGROUND:":[0],"Chemotherapy-induced":[1],"nausea":[2],"and":[3,13,31,45,66,71,82,92,95,113,180,192,221,257,273,286,328,336],"vomiting":[4],"(CINV)":[5],"can":[6],"lead":[7],"to":[8,18,123,143,151,171,314],"increased":[9,19],"emergency":[10,178,259,329],"department":[11,260,330],"visits":[12,183,261,331],"hospitalizations,":[14],"which":[15],"may":[16,318],"contribute":[17],"cost":[20],"of":[21,57,80,154,162,201,209,234,253,301,308],"care.":[22],"Antiemetic":[23],"agents,":[24],"such":[25,323],"as":[26,324],"neurokinin-1":[27],"(NK1)":[28],"receptor":[29,34,60,64,157,189,195,218,228,248,270,283,295,310],"antagonists":[30,296],"5-hydroxytryptamine":[32],"(5-HT3)":[33],"antagonists,":[35],"are":[36],"prescribed":[37],"for":[38,111,332],"patients":[39,87,96,126,147,185,203,235,291,333],"receiving":[40,130,236,267,280,292,334],"highly":[41,335],"emetogenic":[42,47,338],"chemotherapy":[43,48],"(HEC)":[44],"moderately":[46,337],"(MEC).":[49],"The":[50,146,250,290],"current":[51,315],"guidelines":[52,317],"recommend":[53],"a":[54,62,281,298],"3-drug":[55],"combination":[56],"an":[58,155,216,246,268,293],"NK1":[59,156,188,217,247,269,294,309],"antagonist,":[61,65],"5-HT3":[63],"dexamethasone":[67],"with":[68,127,132,176],"HEC":[69,91],"regimens":[70,94,312],"certain":[72],"MEC":[73,93],"regimens.":[74,100],"OBJECTIVE:":[75],"To":[76],"compare":[77],"the":[78,152,187,193,207,265,278,306],"incidence":[79,251],"CINV":[81,173,255],"CINV-related":[83,258,325],"resource":[84,302,321],"utilization":[85],"among":[86,184],"who":[88,97],"receive":[89,98],"guideline-adherent":[90],"non-guideline-adherent":[99],"METHODS:":[101],"In":[102],"this":[103],"retrospective,":[104],"claims-based":[105],"study,":[106],"Inovalon's":[107],"Medical":[108],"Outcomes":[109],"Research":[110,118],"Effectiveness":[112],"Economics":[114],"Registry":[115],"(MORE2":[116],"Registry)":[117],"Edition":[119],"database":[120],"was":[121],"used":[122,170,215,226],"identify":[124,172],"8089":[125],"solid":[128],"tumors":[129],"therapy":[131],"anthracycline":[133],"plus":[134],"cyclophosphamide":[135],"(AC),":[136],"cisplatin,":[137],"or":[138,242],"carboplatin":[139,243],"from":[140],"June":[141],"2013":[142],"December":[144],"2013.":[145],"were":[148,169,204,262],"stratified":[149],"according":[150,313],"use":[153,307],"antagonist":[158,190,196,229,271,284],"regimen.":[159],"International":[160],"Classification":[161],"Diseases,":[163],"Ninth":[164],"Revision,":[165],"Clinical":[166],"Modification":[167],"codes":[168],"events":[174,256],"associated":[175],"hospital,":[177,327],"department,":[179],"outpatient":[181],"office":[182],"in":[186,206,264,277],"group":[191,266,279],"non-NK1":[194,227,282],"group.":[197],"RESULTS:":[198],"A":[199,231],"total":[200,254],"1059":[202],"included":[205],"analysis,":[208],"whom":[210],"51%":[211],"(N":[212,223],"=":[213,224],"536)":[214],"antagonist-based":[219],"regimen":[220],"49%":[222],"523)":[225],"therapy.":[230],"higher":[232],"percentage":[233],"AC":[237],"(73%)":[238],"than":[239,276],"cisplatin":[240],"(56%)":[241],"(23%)":[244],"received":[245],"antagonist.":[249],"rates":[252],"lower":[263,299],"(44%":[272],"9%,":[274],"respectively)":[275],"(50%":[285],"15%,":[287],"respectively).":[288],"CONCLUSION:":[289],"had":[297],"rate":[300],"utilization,":[303,322],"suggesting":[304],"that":[305],"antagonist-containing":[311],"national":[316],"reduce":[319],"healthcare":[320],"office,":[326],"chemotherapy.":[339]},"counts_by_year":[{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":5}],"updated_date":"2026-11-03T10:50:19.383937","created_date":"2016-06-24T00:00:00"}